Latest news
New GLP-1 pill delivers up to 12% weight loss in 36 weeks - ScienceDailyScienceDaily · Mon, 10 Aug 2026 14:51:45 GMTUK Approves Eli Lilly's Foundayo Pill for Obesity and Type 2 Diabetes - Global Banking & Finance ReviewGlobal Banking & Finance Review · Mon, 10 Aug 2026 11:46:12 GMTLLY Vs. NVO: Whose Oral Obesity Drug Had Better Launch Reception? - StocktwitsStocktwits · Sat, 08 Aug 2026 02:14:25 GMTOral Weight Loss Pill Helps Patients Lose up to 12% of Body Weight - SciTechDailySciTechDaily · Fri, 07 Aug 2026 18:12:52 GMTThe Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 07:00:00 GMTEli Lilly Surpasses Wall Street Estimates on Injectable GLP-1 Drugs - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 14:12:46 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTLilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom - Fierce PharmaFierce Pharma · Wed, 05 Aug 2026 15:42:35 GMT